In a brief 30-minute reaction, the top performing enzyme achieved a 63% conversion to the desired chiral alcohol and delivered perfect stereoselectivity, meeting the stringent purity requirements for pharmaceutical ingredients.
In a brief 30-minute reaction, the top performing enzyme achieved a 63% conversion to the desired chiral alcohol and delivered perfect stereoselectivity, meeting the stringent purity requirements for pharmaceutical ingredients.
The entire discovery-to-validation cycle was completed in a fraction of the time required for traditional approaches, dramatically de-risking the R&D process, lowering costs, and accelerating the timeline for bringing new products to market.
Create new products and processes, adapt existing ones or develop completely new biochemistry. Zymvol is here to guide you in any stage of your journey.
Go to solutions